Saudi precision medicine is becoming real in clinics, not only in labs. Two names keep appearing in this shift. King Faisal Specialist Hospital & Research Centre (KFSHRC) is building clinical genomic services at scale. King Abdullah University of Science and Technology (KAUST) is helping close a major research gap: genomic references that do not represent local people.
KFSHRC reports rapid growth in testing and capacity. Its genomic testing volume rose from 22,000 tests in 2022 to more than 44,000 in 2024. The same source says KFSHRC remains the only facility in Saudi Arabia offering whole-genome sequencing for diagnosing rare and complex conditions. These kinds of capabilities matter in a country described as having higher-than-average rates of certain rare genetic disorders.
The numbers show the direction of travel at KFSHRC: 22,000 genomic tests in 2022, more than 44,000 in 2024, and a large reproductive genomics program that has run since 2001. Those figures capture how fast services are expanding and how long some programs have been in place.
From Research Representation to Preventive Family Decisions
KAUST-linked research points to a key problem in global genomics: missing representation. A study built a population-specific pangenome graph using Saudi and Japanese samples and called it JaSaPaGe (Japanese Saudi PanGenome). One of the lead authors said that up to 12 percent of patients with genetic disorders go undiagnosed when reference genomes do not reflect their population’s genetic background. The study’s approach is framed as addressing a critical gap in global genomic representation.
At the hospital level, KFSHRC highlights prevention, not only diagnosis. Its Pre-implantation Genetic Testing (PGT) program uses next-generation sequencing to analyze embryos before implantation and identify mutations linked to serious inherited disorders. KFSHRC says the program has served thousands of Saudi families since its launch in 2001. It also describes the program as the largest of its kind in the Middle East in annual case volume, performing nearly half of all comparable procedures conducted across Europe combined.
Prevention is also described in cost terms. KFSHRC cites estimates that preventing the birth of a child with a genetic disorder can save the healthcare system around one million Saudi riyals annually in treatment and care costs. The hospital also says it is broadening the program to cover hundreds of additional mutations and genetic disorders, and it mentions artificial intelligence and whole-genome sequencing to improve precision and speed.
Access is another theme. KFSHRC’s library guide notes a precision medicine service launched in January 2025 in family medicine clinics, in collaboration with the medical genomics department, the family medicine department, and University of Pittsburgh Medical Center. The goal is to enhance access to the latest genetic tests and enable precise diagnostic and treatment plans for individuals and families. International links are also expanding. KFSHRC announced membership in the Global Alliance for Genomics and Health, positioning it in international work to advance precision medicine, accelerate research, and safeguard patient privacy.
What does saudi precision medicine mean in real healthcare terms?
How fast is genomic testing growing at KFSHRC?
Why do population-specific genomes matter for Saudi Arabia?
What is KFSHRC’s pre-implantation genetic testing (PGT) program used for?
